| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.4 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |